1. Exploiting mechanoregulation via FAK/YAP to overcome platinum resistance in ovarian cancer.
- Author
-
Dang LN, Choi J, Lee E, Lim Y, Kwon JW, and Park S
- Subjects
- Female, Humans, Animals, Cell Line, Tumor, Antineoplastic Agents pharmacology, Adaptor Proteins, Signal Transducing metabolism, Mice, Xenograft Model Antitumor Assays, Mice, Inbred BALB C, Mechanotransduction, Cellular drug effects, Cell Proliferation drug effects, Signal Transduction drug effects, Ovarian Neoplasms drug therapy, Ovarian Neoplasms pathology, Ovarian Neoplasms metabolism, Drug Resistance, Neoplasm drug effects, Cisplatin pharmacology, YAP-Signaling Proteins metabolism, Apoptosis drug effects, Mice, Nude, Focal Adhesion Kinase 1 metabolism, Transcription Factors metabolism
- Abstract
Cancer cells mechanically interact with the tumor microenvironment during cancer development. Mechano-reciprocity has emerged as a crucial factor affecting anti-cancer drug resistance during adjuvant therapy. Here, we investigated the focal adhesion kinase (FAK)/Yes-associated protein (YAP) signaling axis as a prospective strategy for circumventing cisplatin resistance in ovarian cancer (OC). The Cancer Genome Atlas (TCGA) data analysis revealed that FAK overexpression significantly correlated with unfavorable clinical outcomes in patients with ovarian cancer. AFM indentation experiments showed that cell elasticity depends on FAK activity. Notably, the combination of FAK inhibition and cisplatin treatment led to a 69 % reduction in the IC
50 of cisplatin. This combined treatment also increased apoptosis compared to the individual treatments, along with the upregulation of the pro-apoptotic factor BAX and cleaved PARP. Suppressing FAK expression sequestered YAP in the cytosol, potentially reducing cellular proliferation and promoting apoptosis. Moreover, reduced FAK expression sensitized drug-resistant OC cells to cisplatin treatment owing to a decrease in nuclear tension, allowing the relocation of YAP to the cytosol. In a mouse model, the co-administration of an FAK inhibitor and cisplatin significantly suppressed tumor growth and increased apoptotic events and DNA fragmentation. Our findings suggest that drug resistance can be attributed to the perturbation of mechanosensing signaling pathways, which drive the mechanical reinforcement of cancer cells. OC cells can restore their sensitivity to cisplatin treatment by strategically reducing YAP localization in the nucleus through FAK downregulation., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF